Market Tracker

01/20 5:16pm ET

Merus Labs International Inc (NASDAQ:MSLI)

0.7999
Delayed Data
As of Jan 20
 +0.0299 / +3.88%
Today’s Change
0.70
Today|||52-Week Range
1.90
-8.06%
Year-to-Date
What Makes Merus Labs (MSLI) a Strong Sell?
Jan 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close0.77
Today’s open0.78
Day’s range0.76 - 0.80
Volume9,400
Average volume (3 months)24,830
Market cap$90.1M
Dividend yield--
Data as of 2:47pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-3,133.33%
Earnings growth (this year)+47.48%
Earnings growth (next 5 years)+1.14%
Revenue growth (last year)+72.51%
P/E ratio--
Price/Sales1.62
Price/Book0.60

Competitors

 Today’s
change
Today’s
% change
CRMECardiome Pharma Corp+0.07+2.47%
TTNPTitan Pharmaceutical...-0.10-2.35%
VCELVericel Corp-0.05-1.82%
CATBCatabasis Pharmaceut...-0.47-9.46%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 15, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$68.7M
Annual profit (last year)-$7.1M
Net profit margin-10.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Barry Fishman
Chief Financial Officer
Michael Bumby
Corporate headquarters
Toronto, Ontario

Forecasts